Cargando…
Post-COVID Syndrome: An Insight on Its Pathogenesis
Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of COVID-19 characterize the post-COVID syndrome. Its incidence ranges from 10% to 35%, however, rates as high as 85% have...
Autores principales: | Maltezou, Helena C., Pavli, Androula, Tsakris, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151752/ https://www.ncbi.nlm.nih.gov/pubmed/34066007 http://dx.doi.org/10.3390/vaccines9050497 |
Ejemplares similares
-
Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals
por: Pavli, Androula, et al.
Publicado: (2021) -
Middle East respiratory syndrome coronavirus (MERS-CoV): Prevention in travelers
por: Pavli, Androula, et al.
Publicado: (2014) -
Travel vaccines throughout history
por: Pavli, Androula, et al.
Publicado: (2022) -
Legal aspects of public health: How law frames communicable disease control in Greece
por: Hatzianastasiou, Sophia, et al.
Publicado: (2011) -
In-flight transmission of COVID-19 on flights to Greece: An epidemiological analysis
por: Pavli, Androula, et al.
Publicado: (2020)